A61K 35/34
Muscles
Official title: Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes (vascular smooth muscle A61K35/44)
A61K35/34 (Muscles) appears on 643 US grants and 1,253 published applications in this corpus.
Search patents in A61K- Granted patents
- 643
- Published applications
- 1,253
- Assignees
- 547
- Inventors
- 1,880
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 4 | 0 |
| 1998 | 5 | 0 |
| 1999 | 5 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 10 |
| 2002 | 6 | 12 |
| 2003 | 5 | 10 |
| 2004 | 7 | 17 |
| 2005 | 4 | 21 |
| 2006 | 3 | 25 |
| 2007 | 4 | 42 |
| 2008 | 5 | 26 |
| 2009 | 4 | 29 |
| 2010 | 8 | 36 |
| 2011 | 13 | 25 |
| 2012 | 19 | 39 |
| 2013 | 23 | 71 |
| 2014 | 40 | 65 |
| 2015 | 45 | 86 |
| 2016 | 32 | 75 |
| 2017 | 42 | 55 |
| 2018 | 51 | 74 |
| 2019 | 37 | 81 |
| 2020 | 38 | 90 |
| 2021 | 32 | 83 |
| 2022 | 46 | 75 |
| 2023 | 41 | 62 |
| 2024 | 43 | 54 |
| 2025 | 32 | 59 |
| 2026 | 23 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions of chondrisomes6 Oct 2026US 12,751,977 B2Children's Medical Center Corporation
- Gene-therapy vectors for treating cardiomyopathy29 Sep 2026US 12,747,453 B2
- Gene-therapy vectors for treating cardiomyopathy22 Sep 2026US 12,742,181 B2
- KLF induced cardiomyogenesis8 Sep 2026US 12,729,226 B2National Cerebral and Cardiovascular Center
- Satellite cells and compositions and methods for producing the same25 Aug 2026US 12,716,056 B2President and Fellows of Harvard College
- Universal treatment of down syndrome1 Oct 2026US 2026/0294978 A1DEI Biopharma
- Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy17 Sep 2026US 2026/0272990 A1Cedars-Sinai Medical Center
- Methods for treating facioscapulohumeral muscular dystrophy10 Sep 2026US 2026/0263526 A1Fred Hutchinson Cancer Center
- Platelet rich plasma formulations20 Aug 2026US 2026/0240910 A1Blue Engine Biologics, LLC
- Reacted matrix for cell dispersion6 Aug 2026US 2026/0224614 A1The Texas A&M University System
Most cited
By later US patents
- Central occluder semi-biological heart valve842US 4,612,011 A1986
- Mesenchymal stem cells for cartilage repair617US 5,906,934 AMorphoGen Pharmaceuticals, Inc. · 1999
- Mesenchymal stem cells for cartilage repair337US 6,214,369 B1MorphoGen Pharmaceuticals, Inc. · 2001
- Tissue formation by injecting a cell-polymeric solution that gels in vivo318US 5,709,854 AMassachusetts Institute of Technology · 1998
- Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor154US 4,553,974 AMayo Foundation · 1985